Product NewsDrug discovery > Lead Discovery BioAlliance Pharma annonce les résultats préliminaires de l’essai clinique de Phase I/II de doxorubicine Transdrug® pour le traitement du cancer primitif du foie
Product NewsDrug discovery > Lead Discovery US Phase III study of Avastin in advanced pancreatic cancer does not meet primary endpoint
Product NewsDrug discovery > Clinical Development ClinPhone Launches Ground-Breaking Drug Accountability Solution For Clinical Trials
Product NewsDrug discovery > Lead Discovery Reprise prochaine du recrutement dans l'étude internationale de phase III AVANT sur le traitement adjuvant postopératoire du cancer du côlon
Product NewsDrug discovery > Lead Discovery La chimiothérapie orale Xeloda s'avère efficace contre le cancer de l'estomac
Product NewsDrug discovery > Clinical Development Oxford Biomedica reports new encouraging phase II results with TroVax® and progress in the development plan
Product NewsDrug discovery > Clinical Development TopoTarget and CuraGen Initiate NCI-sponsored Phase II Clinical Trial of PXD101 for Acute Myelogenous Leukemia
Product NewsDrug discovery > Lead Discovery Study in the journal vaccine reports positive results of DNA-based Flu vaccine in Humans
Product NewsDrug discovery > Lead Discovery Avastin filed with FDA in US for treatment of women with advanced breast cancer
Product NewsDrug discovery > Clinical Development CeNeS announces the publication of an important independent review of its lead product, M6G
Product NewsDrug discovery > Clinical Development Oxford Biomedica commences phase II trial of TroVax® in prostate cancer
Product NewsDrug discovery > Clinical Development Oxford Biomedica secures agreement with FDA on special protocol assessment for phase III trial of TroVax in renal cancer
Product NewsDrug discovery > Clinical Development BioAlliance Pharma starts pivotal Phase III clinical trial in the US of Loramyc® treatment for oropharyngeal candidiasis
Product NewsDrug discovery > Clinical Development BioAlliance Pharma démarre une étude clinique pivot de phase III aux Etats-Unis pour le Loramyc® dans le traitement de la candidose oropharyngée
Product NewsDrug discovery > Clinical Development ClinPhone and HTS Introduce New Memory Enhancing Technique to Improve Reliability of Clinical Trial Results
Product NewsDrug discovery > Clinical Development Faust Pharmaceuticals announces Phase IIa clinical trial results for treatment of amyotrophic lateral sclerosis (ALS)
Product NewsLife Sciences Unmet Medical Needs, Positive Regulatory Frameworks and Increased Investments Support Continued Stem Cell Research
Product NewsDrug discovery > Lead Discovery TopoTarget reports promising Phase II trial results with Avugane™ in acne vulgaris
Product NewsDrug discovery > Lead Discovery TopoTarget and CuraGen present encouraging new preclinical data on PXD101 at the AACR 97th Annual Meeting
Product NewsDrug discovery > Lead Discovery PowderMed’s Therapeutic DNA Vaccine for Chronic Hepatitis B Enters Phase I Clinical Trials in Patients
Product NewsDrug discovery > Lead Discovery TopoTarget and CuraGen announce initiation of first NCI-sponsored clinical trial with PXD101
Product NewsDrug discovery > Lead Discovery Astech Projects’ new automated inhaler tester accommodates any design
Product NewsLife Sciences Oxford Biomedica plc preliminary results for the year ended 31 December 2005
